Evidence map›Paper›PMID 15003970›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2004

High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease.

H Bryan Brewer

Registry-linked trialAbstract readCommentEditorial
PubMed Publisher
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00458055 (Treatment Study for Severe High-Density Lipoprotein Deficiency), which is not on this map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00458055 nacompletedstarted 2006, after this paper: background citation

Treatment Study for Severe High-Density Lipoprotein Deficiency

Ran2006Enrolled19Registered outcomes2Posted comparisons0ConditionsCoronary Arteriosclerosis, Genetic Diseases, Inborn, HypoalphalipoproteinemiasArmsAtorvastatin; Fenofibrate; Niacin
Open the trial in the graph
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. A Study on Multiple Facets of Apolipoprotein A1 Milano.Applied biochemistry and biotechnology · 2023
    Review
  9. Article
  10. HDL and Cholesterol Ester Transfer Protein (CETP).Advances in experimental medicine and biology · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Vulnerable plaque: from bench to bedside; local pacification versus systemic therapy.Heart views : the official journal of the Gulf Heart Association · 2012
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

H Bryan Brewer

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsArteriosclerosisBiological TransportCardiovascular DiseasesCarrier ProteinsCholesterolCholesterol Ester Transfer ProteinsCholesterol, HDLEnzyme InhibitorsGlycoproteinsHumansLipoproteins, HDLLiverMacrophagesMiceMice, TransgenicCarrier ProteinsCETP protein, humanCholesterolCholesterol Ester Transfer ProteinsCholesterol, HDLEnzyme InhibitorsGlycoproteinsLipoproteins, HDLQuinolinestorcetrapib

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.